Kala Stock Analysis Kala Bio Inc. Drops 5.83 To 0.16 Biotech Performance Review 20260401 RBKB Q1 2026 Earnings EPS of 020 Reported Amid Stock Decline Enhabit Inc EHAB Q4 2025 Earnings EPS Misses Estimates by a Narrow Margin Stock Edges Higher Ernexa Therapeutics Q3 2023 Earnings Losses Deepen as Stock Declines No Revenue Reported CTOR Q1 2026 Earnings EPS Falls Far Below Estimates as PreRevenue Company Continues RD Investment Karooooo Ltd KARO Q1 2026 Earnings EPS Misses by 196 Yet Stock Gains 23 Achieve Life Sciences Q1 2026 Earnings NarrowerthanExpected Loss Drives Optimism